Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1999 2
2001 1
2004 2
2005 2
2006 2
2011 2
2012 1
2019 1
2020 1
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

14 results
Results by year
Filters applied: . Clear all
Page 1
Hypereosinophilic syndrome: an update.
Wilkins HJ, Crane MM, Copeland K, Williams WV. Wilkins HJ, et al. Am J Hematol. 2005 Oct;80(2):148-57. doi: 10.1002/ajh.20423. Am J Hematol. 2005. PMID: 16184589 Free article. Review.
Phase 1 Open-Label, Multicenter Study of First-in-Class RORγ Agonist LYC-55716 (Cintirorgon): Safety, Tolerability, and Preliminary Evidence of Antitumor Activity.
Mahalingam D, Wang JS, Hamilton EP, Sarantopoulos J, Nemunaitis J, Weems G, Carter L, Hu X, Schreeder M, Wilkins HJ. Mahalingam D, et al. Among authors: wilkins hj. Clin Cancer Res. 2019 Jun 15;25(12):3508-3516. doi: 10.1158/1078-0432.CCR-18-3185. Epub 2019 Feb 28. Clin Cancer Res. 2019. PMID: 30819679 Free article. Clinical Trial.
Emerging therapeutic targets in psoriasis.
Bayliffe AI, Brigandi RA, Wilkins HJ, Levick MP. Bayliffe AI, et al. Among authors: wilkins hj. Curr Opin Pharmacol. 2004 Jun;4(3):306-10. doi: 10.1016/j.coph.2004.02.003. Curr Opin Pharmacol. 2004. PMID: 15140425 Review.
Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial.
Spergel JM, Rothenberg ME, Collins MH, Furuta GT, Markowitz JE, Fuchs G 3rd, O'Gorman MA, Abonia JP, Young J, Henkel T, Wilkins HJ, Liacouras CA. Spergel JM, et al. Among authors: wilkins hj. J Allergy Clin Immunol. 2012 Feb;129(2):456-63, 463.e1-3. doi: 10.1016/j.jaci.2011.11.044. Epub 2011 Dec 28. J Allergy Clin Immunol. 2012. PMID: 22206777 Clinical Trial.
Physician-owned groups: the best strategy for success.
Wilkins HJ, Pierotti RJ, Motley RJ, Cohan HD, Conrad JL, Derstine RL, Mertzanis P, Bender AD. Wilkins HJ, et al. Fam Pract Manag. 1999 May;6(5):38-41. Fam Pract Manag. 1999. PMID: 10537796 Free article. Review. No abstract available.
Erectile response with vardenafil in sildenafil nonresponders: a multicentre, double-blind, 12-week, flexible-dose, placebo-controlled erectile dysfunction clinical trial.
Carson CC, Hatzichristou DG, Carrier S, Lording D, Lyngdorf P, Aliotta P, Auerbach S, Murdock M, Wilkins HJ, McBride TA, Colopy MW; Patient Response with Vardenafil in Slidenafil Non-Responders (PROVEN) Study Group. Carson CC, et al. Among authors: wilkins hj. BJU Int. 2004 Dec;94(9):1301-9. doi: 10.1111/j.1464-410X.2004.05161.x. BJU Int. 2004. PMID: 15610110 Clinical Trial.
Extended duration of efficacy of vardenafil when taken 8 hours before intercourse: a randomized, double-blind, placebo-controlled study.
Porst H, Sharlip ID, Hatzichristou D, Rubio-Aurioles E, Gittelman M, Stancil BN, Smith PM, Wilkins HJ, Pommerville P; Vardenafil Study Group. Porst H, et al. Among authors: wilkins hj. Eur Urol. 2006 Nov;50(5):1086-94; discussion 1094-5. doi: 10.1016/j.eururo.2006.05.036. Epub 2006 Jun 8. Eur Urol. 2006. PMID: 16820261 Clinical Trial.
14 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page